MedTrace Logo

Effects of Spirulina on Cardiac Functions in Children With Beta Thalassemia Major

NCT02597595 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2018-09-11

No results posted yet for this study

Summary

The aim of this study is to evaluate the cardioprotective effect of spirulina in children with beta thalassemia.

Conditions

  • Beta Thalassemia

Interventions

OTHER

spirulina

oral spirulina (tablet=500mg) will be given to patients for 3 months in a dose of 250 mg/kg/day (maximum 4 gm)

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Principal Investigators

  • Magda M Ibrahim, M.B.B.ch · Master Degree student

  • Osama AR Tolba, MD · supervisor

  • Rasha M Gamal, MD · supervisor

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2017-10-31
Completion
2017-10-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02597595 on ClinicalTrials.gov